Sun Chemical, a resident of BioArk’s technological site in Monthey, has appointed Boris Jud-Fleet as its new director since September.
Sun Chemical: new director and upcoming hires at the Monthey Site! Read More »
Together, let’s continue to make the Valais a fertile breeding ground for the life sciences.
Together towards new horizons: our wishes for 2025 Read More »
Siegfried, a leading global CDMO for the pharmaceutical industry headquartered in Zofingen, Switzerland, has inaugurated its new global Research and Development center at its site in Evionnaz, located in the Valais canton.
Siegfried opens new global R&D Center for Drug Substances in Evionnaz Read More »
Exclusive program in French-speaking Switzerland combines life sciences expertise with advanced digital skills to meet industry demands
HES-SO Valais-Wallis Launches Innovative Digital Life Sciences Program Read More »
Founded in 2012 at the BioArk technology site in Monthey and supported by the Ark Foundation’s incubator during its start-up phase, CordSavings is now establishing itself as a major player in the field of umbilical cord stem cell preservation. Combining scientific expertise and ethical commitment, CordSavings is also the only private biobank in Switzerland, offering pregnant women and all families expecting a child the opportunity to collect and store stem cells in Switzerland.
Stem cell and umbilical cord preservation, the reference is in Monthey! Read More »
Lonza strengthens its bioconjugation capacities at Visp, in the canton of Valais, with two new manufacturing suites.
Lonza to Expand Bioconjugation in Visp, with Two Additional Manufacturing Suites Read More »
Final deadline for submitting applications to the Innosuisse call for projects for the Flagship Initiative 2024, focusing on Artificial Intelligence in Life Sciences, with an emphasis on healthcare.
Call for projects AI in Life Sciences – Flagship Initiative Read More »
Precise Health, a biotech start-up based at the Energypolis Campus in Sion, has just won phase 2 of the national Venture Kick competition. The CHF 40,000 prize will enable the company to further develop its technology, which is revolutionizing the treatment of antibiotic-resistant bacterial infections.
Valais start-up Precise Health wins CHF 40,000 Venture Kick prize Read More »
Lonza is expanding its partnership with an undisclosed major pharmaceutical company to supply antibody-drug conjugates (ADCs). This agreement includes building a new facility at Lonza’s Ibex® Biopark in Visp (Valais), Switzerland, and providing large-scale production of monoclonal antibodies for a new ADC treatment.
Lonza builds new plant in Visp, creating 100 new jobs Read More »
From lab bench to pitch perfection : Ninsun’s cancer-fighting innovation just lit up the Innothèque at Foire du Valais last Friday for the Startup Pitch of the Fondation the Ark !
Ninsun is winning the Fondation the Ark’s Startup Pitch Read More »
